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Abstract
Salmonella enterica serovar Infantis is the fifth most common Salmonella serovar isolated in England and Wales. Epidemio-
logical, genotyping and antimicrobial- resistance data for S. enterica Infantis isolates were used to analyse English and Welsh 
demographics over a 5 year period. Travel cases associated with S. enterica Infantis were mainly from Asia, followed by cases 
from Europe and North America. Since 2000, increasing numbers of S. enterica Infantis had multidrug resistance determinants 
harboured on a large plasmid termed ‘plasmid of emerging S. enterica Infantis’ (pESI). Between 2013 and 2018, 42 S. enterica 
Infantis isolates were isolated from humans and food that harboured resistance determinants to multiple antimicrobial classes 
present on a pESI- like plasmid, including extended- spectrum β-lactamases (ESBLs; bla
CTX- M- 65
). Nanopore sequencing of an 
ESBL- producing human S. enterica Infantis isolate indicated the presence of two regions on an IncFIB pESI- like plasmid har-
bouring multiple resistance genes. Phylogenetic analysis of the English and Welsh S. enterica Infantis population indicated that 
the majority of multidrug- resistant isolates harbouring the pESI- like plasmid belonged to a single clade maintained within the 
population. The bla
CTX- M- 65
 ESBL isolates first isolated in 2013 comprise a lineage within this clade, which was mainly associated 
with South America. Our data, therefore, show the emergence of a stable resistant clone that has been in circulation for some 
time in the human population in England and Wales, highlighting the necessity of monitoring resistance in this serovar.
DATA SUMMARY
Public Health England (PHE) and Quadram Institute Biosci-
ence Illumina fastq files are available from the National 
Center for Biotechnology Information (NCBI) BioProject 
PRJNA248792. All Illumina accession numbers are given in 
Table S1 (available with the online version of this article), 
including the Illumina equivalents of the Nanopore sequenced 
samples below.
Nanopore fastq files for Salmonella enterica Infantis isolate 
114061 (BioSample SAMN08732049) are available from 
BioProject PRJNA248792 under Sequence Read Archive 
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assembly can be found under BioProject PRJNA315192 under 
the following accession numbers: chromosome, CP070302; 
pESI, CP070303.
Nanopore fastq files for S. enterica Infantis isolate 91264 
(BioSample SAMN03478587) are available from BioProject 
PRJNA248792 under SRA accession number SRR13674758. 
The corrected 91264 assembly can be found under BioPro-
ject PRJNA315192 under accession number CP070301 
(chromosome).
Supplementary Material can be found on FigShare (at https:// 
doi. org/ 10. 6084/ m9. figshare. 14815824).
INTRODUCTION
Non- typhoidal Salmonella infections are generally self- 
limiting (but may cause disease requiring antimicrobial 
treatment), cause an estimated 93.8 million global cases per 
annum, with approximately 86 % of these being foodborne 
gastroenteritis cases [1]. The prevalence of various serovars 
differs across the world, with Salmonella enterica serovar 
Infantis emerging as the fourth most common serovar in 
humans across Europe [2]. The population structure of S. 
enterica Infantis isolates in England and Wales consists of two 
eBurst groups (eBGs), eBG31 and eBG297, with eBG31 being 
the predominant group [3]. This serovar is also dominant in 
animal reservoirs, especially in poultry where it accounted for 
36.7 % of isolates in Europe in 2018 [4–6]. Widespread use of 
antimicrobials in the animal production industry contributes 
to antimicrobial resistance (AMR) and the dissemination of 
S. enterica Infantis into the food chain, with transmission to 
humans a growing public- health concern [7, 8].
The increasing incidence of S. enterica Infantis may be compli-
cated by the acquisition of resistance to medically important 
antimicrobials. Many resistance determinants are harboured 
on mobile genetic elements such as plasmids that are found 
and circulate within the bacterial kingdom. Emerging S. 
enterica Infantis isolates harbouring plasmids carrying 
multiple resistance determinants have been reported recently, 
with one of the first cases being reported in Israel [9]. The 
plasmid described, ∼280 kbp in size, contained genes confer-
ring resistance to tetracycline, trimethoprim, sulfamethoxa-
zole, antiseptics and heavy metals, and was termed 'plasmid 
of emerging S. enterica Infantis' (pESI). Furthermore, this 
plasmid contained genes associated with virulence, including 
those encoding yersiniabactin (ybt operon) and fimbriae (fea 
and ipf operons), which enhance the colonization capability 
and fitness of the bacterium [9]. Similar pESI- like plasmids 
that have evolved to confer resistance to extended- spectrum 
β-lactams via the acquisition of blaCTX- M- 1 and blaCTX- M- 65 genes 
have been reported across the globe, including the United 
States, South America and Europe [4–11].
Whole- genome sequencing (WGS) has been used by Public 
Health England (PHE) since April 2014 for supporting 
outbreak investigations, studying Salmonella population 
structures and understanding Salmonella pathogenicity 
[3, 12]. Characterization of Salmonella genomes with WGS 
using bioinformatics provides the ability to screen and differ-
entiate the resistance genes present, as well as characterize 
drug- resistance regions, which cannot be carried out with 
phenotypic antimicrobial- susceptibility tests [13, 14].
Although recent studies have described the emergence of 
multiple- drug resistant (MDR) and extended- spectrum 
β-lactamase (ESBL)- producing S. enterica Infantis in multiple 
countries, it has not been well described in England and Wales 
[8, 15]. Therefore, the aim of this study was to use passive 
surveillance and WGS to investigate the epidemiology, 
population structure and AMR of current and historical S. 
enterica Infantis isolates from humans and poultry- related 
food sources in England and Wales.
METHODS
Bacterial isolates and datasets
S. enterica Infantis isolates (n=624) from eBG31 collected 
by the Gastrointestinal Bacterial Reference Unit (GBRU), 
PHE, from local and regional hospitals in England and 
Wales between 13.09.2013 and 14.11.2018 were sequenced at 
PHE in this study (Table S1). To ascertain whether the MDR 
isolates had been circulating in the human population and 
whether there was a potential historical source, a further 171 
historical isolates (prior to the implementation of WGS) from 
the GBRU culture stores, isolated between 2000 and 2013, 
were also sequenced at Quadram Institute Bioscience. Human 
isolates were sourced from urine, blood or from cases with 
Impact Statement
Whole- genome sequencing (WGS) has revolutionized 
public- health microbiology and has been used routinely at 
Public Health England since April 2015 for identification, 
epidemiological surveillance and monitoring antimicro-
bial resistance (AMR). Analysing WGS data allows the in 
silico interrogation of emerging resistance determinants, 
aids in investigating mechanisms conferring resistance 
and enables characterization of drug- resistance regions. 
Integration of WGS data with epidemiological informa-
tion supports tracking of transmission and AMR in the 
Salmonella population and, hence, assists in assessing 
the risk to public health. In this study, in silico gene detec-
tion and phylogenetic analysis identified the presence of 
multidrug- resistant Salmonella enterica Infantis isolates 
with extended- spectrum β-lactamase AMR determinants 
harboured on a megaplasmid (pESI- like plasmid) in the 
English and Welsh human population. This pESI- like 
plasmid seems to be maintained in the human population 
and has been reported both in human and poultry popu-
lations in many regions of the world. Understanding AMR 
carriage and transmission patterns provides information 
to support appropriate clinical management and inform 
implementation of public- health control measures.
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a history of foreign travel, and food isolates associated with 
poultry were given preference. Phylogenetic analysis, AMR 
analysis and pESI- like plasmid detection were carried out 
on these 795 genomes (Table S1). Thirty isolates predicted 
to have ESBL determinants were subjected to antimicrobial- 
susceptibility testing (Table S2). The dataset selected for the 
demographic study included 943 S. enterica Infantis isolates 
that were sequenced at PHE (of which 528 isolates were used 
for the phylogenetic analysis), derived solely from human 
cases between January 2014 to December 2018 (Table S3).
Demographics
Demographic data for all the 943 human S. enterica Infantis 
isolates from England and Wales (Table S3) stored in the PHE’s 
in- house Gastro Data Warehouse (GDW) were obtained. Data 
containing age, gender, geography, date of isolation, travel 
history, serovar identification and antimicrobial susceptibility 
were extracted for analysis. WGS data were also available for 
these isolates for in silico AMR typing (Table S2). Ethical 
approval was not required for this study as PHE is permitted 
to process these data for surveillance purposes, outlined in 
the National Health Service Act 2006.
Antimicrobial-susceptibility testing
Minimum inhibitory concentrations (MICs) were available 
for 30 isolates exhibiting ESBL genotypes (Table S2). These 
were determined by agar dilution using Mueller–Hinton agar 
for the standard panel of antibiotics recommended by the 
European Committee on Antimicrobial Susceptibility Testing 
(EUCAST). EUCAST breakpoints and screening concentra-
tion criteria were used for interpretation (https:// eucast. 
org/ clinical_ breakpoints/). Confirmation of azithromycin 
MIC was performed by EtestVR (bioMérieux). Temocillin 
and cefoxitin were included in the panel to aid detection 
of OXA- 48- like carbapenemases and AmpC production, 
respectively. ESBL detection was confirmed using aztreonam, 
cefotaxime/cefotaxime+clavulanic acid (4 µg ml−1), ceftazi-
dime/ceftazidime+clavulanic acid (4 µg ml−1) and cefepime/
cefepime+clavulanic acid (4 µg ml−1)
Illumina sequencing and data processing
Genomic DNA extraction of S. enterica Infantis isolates was 
carried out using a modified protocol of the QIAsymphony 
DSP DNA midi kit (Qiagen) as described by Nair et al. [14]. 
Extracted genomic DNA was then prepared using the Nexte-
raXT method and sequenced with a standard 2×101 bp FAST 
protocol on a HiSeq 2500 instrument (Illumina). Trimmo-
matic (v0.27) was used to trim sequence data with leading and 
trailing at <Q30 [16]. The 171 historical S. enterica Infantis 
isolates were sequenced at Quadram Institute Bioscience on 
the Illumina NextSeq platform, following methods described 
by Rasheed et al. [17], demultiplexed on climb [18] and 
trimmed using Trimmomatic (v0.36).
Genotyping
Sequence type (ST) and serovar were determined from the 
reads using most (v1.0) as previously described by Tewolde et 
al. [19] and eBG as described by Achtman et al. [20]. Plasmid-
Finder (v2.1) (http:// cge. cbs. dtu. dk/ services/ PlasmidFinder/) 
was used to detect the presence of known replicon types of 
plasmids in the isolates studied [21].
In silico AMR typing
Resistance genes for the 943 human isolates used for the 
demographic study were identified using GeneFinder (https:// 
github. com/ phe- bioinformatics/ gene_ finder), a customized 
algorithm that uses Bowtie2 (v2.3.5.1) [22] to align reads 
to a set of reference sequences and SAMtools (v1.8) [23] to 
generate an mpileup file, as previously described by Day et al. 
[24]. Briefly, the data are parsed based on read coverage of the 
query sequence (100%), consensus base- call on variation (>85 
%) and the nucleotide identity (>90 %) to determine the pres-
ence of the reference sequence or nucleotide variation within 
that sequence. β- Lactamase variants were determined with 
100 % identity using the reference sequences downloaded 
from ResFinder (https:// cge. cbs. dtu. dk/ services/ ResFinder- 4. 
0/) or National Center for Biotechnology Information (NCBI) 
(https://www. ncbi. nlm. nih. gov/ pathogens/ beta- lactamase- 
data- resources) β-lactamase data resources. Known acquired 
resistance genes and resistance- conferring mutations relevant 
to β-lactams, fluoroquinolones, aminoglycosides, chloram-
phenicol, macrolides, sulfonamides, tetracyclines, trimetho-
prim, rifamycins and fosfomycin were included in the analysis 
[25, 26] (Table S2).
In silico AMR typing was also performed using ariba (v2.10.1) 
on the 624 S. enterica Infantis isolates and the 171 historical 
S. enterica Infantis isolates used for the WGS analyses [27]. 
aac(6’)- Iaa was excluded from all calculations as it is known 
to be a cryptic resistance gene (Tables S2 and S4).
Nanopore sequencing and data processing
Nanopore sequencing was performed on two occasions, the 
first was to sequence isolate 91264 (SRR1968494) to act as 
a reference in the reconstruction of a phylogenetic tree for 
eBG31. The second instance was to sequence human- derived 
isolate 114061 (SRR6854755), to characterize the drug 
resistance determinants as it exhibited extended- spectrum 
β-lactam and multidrug resistance, as well as the presence of 
an IncFIB plasmid (Tables S1 and S3).
Both isolates 114061 (SRR6854755) and 91264 (SRR1968494) 
were cultured and genomic DNA extracted using a Fire 
Monkey kit (RevoluGen) following the manufacturer’s 
instructions except for the incubation period with lysozyme, 
which was increased to 1 h. Library preparation was 
performed using the Rapid Barcoding kit SQK- RBK004 
(Oxford Nanopore Technologies). The prepared library was 
loaded on a FLO- MIN106 R9.4.1 flow cell (Oxford Nanopore 
Technologies) and sequenced on the MinION system (Oxford 
Nanopore Technologies) for 48 h using MinKNOW software 
(v1.18).
Isolate 91264 (SRR1968494) was basecalled using Albacore 
(v2.0.1) (Oxford Nanopore Technologies). The fastq output 
was assembled using Canu (v1.7) with default parameters but 
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for useGrid=false [28]. The assembly was then polished using 
the Nanopolish methylation dcm option, flag min- candidate- 
frequency 0.5 using bwa (v0.7.17) [29] and SAMtools (v1.8), 
followed by polishing using Pilon (v1.22) and Racon (v1.3.2) 
[30, 31] with the Illumina- generated reads for isolate 91264 
(SRR1968494).
Isolate 114061 (SRR6854755) was basecalled using Albacore 
(v2.1) (Oxford Nanopore Technologies), converted to fastq 
format and then demultiplexed. The reads (fastq) were then 
trimmed using Porechop v0.2.0 [32], removing sequencing 
adapters and barcodes. Reads (fastq) were then filtered using 
Filtlong (v0.1.1) [33], the highest quality and longest reads 
(worth 50× coverage of the average Salmonella genome) were 
taken for further processing.
The filtered and trimmed fastq reads were then assembled 
using Flye (v2.6) [34] with the --plasmids parameter enabled. 
Correction of the assembly of the isolate was conducted in 
concordance to Yara et al. [35]. The assemblies were corrected 
in a three- step process. Nanopolish (v0.10.2) [36] was utilized 
for trimmed Oxford Nanopore Technology (ONT) fastq 
and fast5 reads generated for each sample using --fix- 
homopolymer, --methylation- aware=dcm,dam and --min- 
candidate- frequency=0.1. Secondly, Pilon (v1.22) [31] was 
used with Illumina fastq reads as the query dataset with the 
use of bwa (v0.7.17) and SAMtools (v1.7) on the assembly. 
Finally, Racon (v1.2.1) also using bwa (v0.7.17) and SAMtools 
(v1.7) was used with the Illumina reads for two cycles to 
produce a final assembly.
Characterization of the region encoding β-lactam 
and other resistance determinants
The assembled S. enterica Infantis isolate (114061) 
(SRR6854755) genome was visualized with Bandage (v.0.6.2) 
[37] (Fig. S1). blastn (v5) ( blast. ncbi. nlm. nih. gov/ Blast. cgi) 
was used to detect AMR genes, in particular genes associ-
ated with ESBL- producing S. enterica Infantis isolates as 
previously described such as blaCTX- M- 65, fos- 3A, tetA, dfrA14, 
sul1 and floR, and their location in the assembly graph [5]. 
Prokka (v1.12) was used to annotate genome sequences 
(http://www. ncbi. nlm. nih. gov/ pubmed/ 24642063) [38] and 
Artemis (v18.00) (www.  sanger. ac. uk/ tool/ artemis) was used 
to visualize the resistance regions [39]. The orientation and 
position of specific genes were drawn using Easyfig (v2.1) 
[40].
brig (v0.95) [41] was used with blast+ (https:// blast. 
ncbi. nlm. nih. gov/ Blast. cgi) parameters of 95 % sequence 
similarity and an E value of 1×10–10 to compare the IncFIB 
pESI plasmid isolated from an ESBL- producing S. enterica 
Infantis in chickens from the United States (CP016409.1) 
and the pESI plasmid from the S. enterica Infantis found 
in Israel (ASRF01000000.1) to the UK pESI plasmid 
(CP070303.1) from sample 114061 (SRR6854755) (of 
human origin) in this study. The output image displays the 
degree of similarity between the ring of reference in the 
centre and the genome of the isolates used.
Identification of pESI presence
Seven hundred and ninety- five S. enterica Infantis isolates 
(including the 171 historical isolates) were analysed (Table 
S1). The presence of pESI in each of the genomes was 
determined using a pESI pseudomolecule that was created 
with the long- read sequenced eBG31 reference genome 
and the pESI contigs from the whole- genome assembly 
of an Israeli human S. enterica Infantis (ASRF01000099–
ASRF01000108). The sequences were mapped against 
this pseudomolecule using smalt (v0.7.6) (seed=5); 
coverage was then determined using SAMtools (v1.8) [23]. 
Heatmaps of pESI coverage were generated, with a read 
depth of 20 signifying presence, using R (v3.5) with the 
packages  data. table (v1.11.8), phytools (v0.6–63) and ape 
(v5.2) [42–45]. The heatmaps were analysed to determine 
which isolates contained pESI. Absence of the plasmid 
was defined as a read depth below 20 in over 50 % of the 
plasmid (Table S1).
The presence of pESI- like plasmid in the 795 S. enterica 
Infantis isolates used for the WGS analysis was also confirmed 
by checking for the presence of the ybtQ (yersiniabactin) and 
ybtX (yersiniabactin), feaG (fimbriae) and ipfC (fimbriae) 
using GeneFinder (https:// github. com/ phe- bioinformatics/ 
gene_ finder) (Table S1). Bandage was utilized to visualize the 
presence of the ybtQ, feag and ipfC genes on the pESI- like 
plasmid from S. enterica Infantis isolate 114061 (SRR6854755) 
(Fig. S2).
Phylogenetic analysis
Phylogenetic analysis of the 795 S. enterica Infantis 
isolates was carried out as follows. The corrected 
assembly of isolate 91264 (SRR1968494) was used as a 
reference genome for the eBG31 SnapperDB (v1.0.6) 
[46]. Illumina fastq reads of the S. enterica Infantis 
genomes were mapped to isolate 91264 using bwa mem 
(v0.7.12) [29]. Variant positions were identified by gatk 
(v3.8.0) Unified Genotyper [47] that passed the following 
parameters: >90 % consensus, minimum read depth of 10, 
mapping quality (MQ) ≥30. Any variants that remained 
were imported in the eBG31 SnapperDB (v1.0.6). The 
eBG31 SnapperDB (v1.0.6) was used to generate a soft- 
core SNP alignment (>80 % consensus) masking recom-
bination, which was detected by Gubbins (v.2.3.1), and 
prophages were detected with phaster [48, 49], also 
any positions where reads could not re- align to self were 
masked. RAxML (v8.2.12) was used with the nucleotide 
substitution model GTRCAT, to reconstruct a maximum- 
likelihood phylogenetic tree that was rooted to its most 
ancestral node [50].
The phylogeny was annotated with pESI and blaCTX- M- 65 pres-
ence using iTOL [51]. The blaCTX- M- 65 clade was extracted 
using FigTree (v1.4.3) and the accompanying figure (genes 
present/absent plotted against phylogeny) generated using 
Phandango [52, 53]. Pairwise SNP distances were calculated 
using mega7 (version 7180411- i3860) [54].
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RESULTS
Demographics
Between January 2014 and December 2018, PHE received 
42 422 human Salmonella isolates from England and Wales, 
where S. enterica Infantis (n=1093, 2.6%) was the fifth most 
common serovar identified. Out of the 943 S. enterica Infantis 
isolates analysed for the demographic study, 917 were from 
eBG31 and 26 belonged to eBG297 (Table S2).
Of the 943 S. enterica Infantis isolates in this study from 
patients in England and Wales, 454 (48.1 %) were isolated 
from females, 487 (51.6 %) were from males and 2 (0.2%) had 
no gender information (Table S3). The incidence of S. enterica 
Infantis infection increased over the study period: in both 
2014 and 2015, 150 isolates were reported; which increased 
to 179, 244 and 218 in 2016, 2017 and 2018, respectively. 
Submission of S. enterica Infantis isolates to PHE peaked 
between July and October for all years studied (Fig. 1, Table 
S3).
Travel-associated S. enterica Infantis cases
Overall, 26.9 % of S. enterica Infantis isolates were isolated 
from patients with travel history. Travel cases associated with 
Fig. 1. Isolation pattern (number of isolates) of S. enterica Infantis isolated at GBRU, PHE, between 01.01.2014 and 31.12.2018.
Fig. 2. Percentage of S. enterica Infantis isolates associated with travel between 2014 and 2018 in England and Wales.
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S. enterica Infantis were mainly to Asia (31.1%), followed by 
North America (24.1%) and Europe (21.4%) (Fig. 2).
In silico AMR detection
Genomes of 943 S. enterica Infantis human isolates used 
for the demographic study, and the 795 S. enterica Infantis 
(human and food) isolates for the phylogenetic analyses, were 
screened for known genes and point mutations associated 
with AMR, including ESBL resistance in Enterobacteriaceae 
(Tables S2 and S4). The presence of blaCTX- M- 65, amongst other 
resistance determinants conferring resistance to β-lactams, 
aminoglycosides, quinolones, tetracycline, trimethoprim, 
sulfonamide, chloramphenicol and fosfomycin, was identi-
fied in 42 S. enterica Infantis genomes (including 2 historical 
isolates – SRR14774811 and SRR14774768 (Table S2). There 
were 35 human isolates and 7 were from food related to 
chicken produce (Table S2). Of the human isolates with 
known travel history, 40.0 % (14/35) were associated with 
travel to South America, while out of the 7 food products, 
6 originated from South America (85.7%). The main resist-
ance profile observed in 25/42 isolates (59.5%) was β-lactam 
(blaCTX- M- 65), aminoglycosides [aph(4)- Ia, aadD, aac(3)- Iva], 
fluoroquinolones [gyrA(87:D- Y)], trimethoprim (dfrA- 14), 
tetracycline [tet(A)−1], sulfonamides (sul- 1), chloramphenicol 
(floR), fosfomycin (fosA- 3) (AMR profile 1); followed by 12/42 
isolates (28.6%) with the same AMR profile except for the 
absence of the fosA gene (AMR profile 2). Two out of forty- two 
(4.8 %) isolates did not have the dfrA- 14 and fosA genes (AMR 
profile 3). One isolate was negative for the tet(A)−1 and sul- 1 
genes (AMR profile 4). One isolate did not have the dfrA- 14 
gene (AMR profile 5), and another was missing the floR gene 
(AMR profile 6) (Table S2). All the isolates (n=42) also had 
genes related to heavy metal resistance, mer (mercury) and 
ars (arsenic). Phenotypic antimicrobial- susceptibility testing 
was performed on 30 of the isolates, which confirmed the 
multidrug- resistance phenotypes predicted from WGS data 
(Table S2).
Location and characterization of AMR determinant 
loci
Nanopore sequencing was carried out to investigate the 
genomic context of the resistance genes in a human- derived 
S. enterica Infantis isolate, 114061 (SRR6854755). Isolate 
114061 had AMR profile 1 and harboured resistance to all 
eight antimicrobial classes described in the study (Table S2). 
Analyses of the 114061 genome indicated that the resistance 
genes and insertion elements (IS26 and tnp) were located 
in two resistance loci (region 1 and region 2) on a 320 kbp 
plasmid that showed 99 % sequence similarity to an IncFIB 
plasmid (NCBI accession no. CP016409) (Figs 3 and S1). 
Region 2 was approximately 21.0 kbp and included resistance 
genes for sulfonamides (sul- 1), aminoglycosides [aph(4)- Ia, 
aph(3)- la, aac(3)- Iva], tetracycline [tet(A)−1] and mercury 
(mer). Region 1 (approximately 36.3 kbp) consisted of the 
blaCTX- M- 65 gene conferring resistance to extended- spectrum 
β-lactam drugs, fosfomycin (fosA- 3), chloramphenicol (floR) 
and aminoglycosides (aadA1), as well as the heavy metal 
arsenic (ars) (Table S2).
Pairwise blastn comparison of IncFIB plasmid 
harbouring β-lactam resistance
The IncFIB plasmid identified in S. enterica Infantis isolate 
114061 (SRR6854755) from a human in this study was 
compared to a known IncFIB plasmid (NCBI accession no. 
CP016409) found in S. enterica Infantis isolated from chickens 
in the USA [5] and the original pESI plasmid (NCBI acces-
sion no. ASRF01000000.1) isolated from a human, detected 
in Israel [9]. The brig plot (Fig. 3) showed 99 % similarity 
between the pESI- like plasmids from the UK human isolate 
and the chicken isolate, with both isolates having identical 
resistance regions (regions 1 and 2) (Fig.  3). There was 
approximately 70 % backbone similarity between the pESI 
plasmid from the Israeli isolate with the other two plasmids, 
with the Israeli plasmid lacking resistance region 1 (Fig. 3).
Presence of pESI-like plasmid, detection of ESBL 
resistance determinants and phylogenetics 
analysis of S. enterica Infantis in England and Wales
Forty- eight per cent (383/795) of the isolates in the domi-
nant eBG in S. enterica Infantis, eBG31 (including historical 
GBRU isolates), harboured a pESI- like plasmid, with the first 
being seen as early as 2000 (Table S1). Phylogenetic analysis 
of the eBG31 population showed that 368 (96 %) pESI- 
positive isolates were present in monophyletic clade 1 and all 
harboured the IncFIB plasmid (Fig. 4a). The 15 isolates that 
were pESI positive but fell outside of clade 1 harboured plas-
mids of different incompatibility groups (8 isolates with IncI1 
plasmid, 6 with IncP plasmid and 1 with an IncA/C plasmid). 
pESI- like plasmids were present in S. enterica Infantis isolates 
from both humans and food (Table S1). Presence of pESI or 
a pESI- like plasmid is associated with multiple- drug resist-
ance (Tables S1 and S4) and resistance to heavy metals in S. 
enterica Infantis [4, 5, 9]. Forty- two S. enterica Infantis isolates 
harbouring the pESI- like plasmid had blaCTX- M- 65 associated 
with extended- spectrum β-lactam resistance. These isolates 
were present in a separate lineage within clade 1 (Fig. 4a). 
The median pairwise SNP distance between the 42 isolates 
within the blaCTX- M- 65 clade was 34 (range 0–68) and the 
median pairwise SNP distance of this blaCTX- M- 65 clade with 
the other isolates in the phylogeny was 157 (range 36–333) 
(Fig. 4a). Another isolate, SRR14774778, that was present in 
this clade did not have blaCTX- M- 65. This isolate was isolated 8 
months (January 2013) before the other isolates in this clade 
(Fig. 4b). Higher resolution of the isolates within this lineage 
showed multiple AMR profiles being present with AMR 
profile 1 (resistance to eight antimicrobial classes) found in 
9/19 of the isolates (Fig. 4b, Tables S2 and S4). Based on the 
samples received at PHE, the first ESBL- producing human 
isolate seen in this study was in 2013 (Table S1). Thirteen 
out of the seventeen ESBL- positive human S. enterica Infantis 
isolates with known travel history were related to travel to 
South America (Fig. 4b, Tables S1 and S2). Six out of the 
seven poultry food products that were ESBL positive were 
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associated with importation from South America (Fig.  4, 
Tables S1 and S2).
DISCUSSION
S. enterica Infantis has been the most prevalent serovar isolated 
from fresh poultry meat and broiler flocks from across Europe 
[6, 54] and human S. enterica Infantis infections are often 
associated with poultry meat [2, 6, 55–58]. Between 2014 and 
2018 in England and Wales, human salmonellosis associated 
with S. enterica Infantis has been increasing, and this serovar 
has now become the fifth most widespread after S. enterica 
Enteritidis (n=12 548, 290.6 %), S. enterica Typhimurium 
including monophasic (n=7930, 180.7 %), S. enterica Newport 
(n=1372, 30.2 %) and S. enterica Typhi (n=1120, 20.6 %) (PHE 
data).
Of the 502 human isolates in England and Wales between 
2014 and 2018 with travel information, 52.3 % were associated 
with travel (Table S3). Most travel- associated cases were 
linked to travel to Asia, followed by North America and 
Europe. An increasing incidence of S. enterica Infantis 
human cases between 2014 and 2018 was observed, with a 
yearly peak between July and October; this could be linked to 
travel- associated cases (2014, 41.4 % cases; 2015, 25.0 % cases; 
2016, 26.8 % cases; 2017, 45.4 % cases; and 2018, 34.0 % cases) 
(Fig. 1), coinciding with the summer holidays.
The change of epidemiology and the increasing incidences of 
MDR clonal lineages of S. enterica Infantis isolates since the 
late 1990s may be related to the development of resistance 
to medically important antimicrobials, including extended- 
spectrum β-lactams [4, 5, 7, 9, 56, 59]. Infections with ESBL- 
producing S. enterica Infantis are particularly concerning 
because they are also commonly resistant to additional classes 
of antimicrobials [4], leaving few treatment options and the 
potential for poorer clinical outcomes [5].
Fig. 3. blast comparison of IncFIB plasmid identified in S. enterica Infantis isolate 114061 (SRR6854755) from a human in this study 
(inner blue ring ring) compared to a known IncFIB plasmid (NCBI accession no. CP016409) found in S. enterica Infantis isolated from 
chickens in the USA (middle green ring) [5] and an S. enterica Infantis human isolate from Israel (outer yellow ring) [9]. Region 1 
consists of the following resistance determinants: bla
CTX- M- 65
 (ESBL); fosA3 (fosfomycin); floR (chloramphenicol); aph(4)- la, aac(3)- IV, 
aph(3)- la (aminoglycosides); dfrA- 14 (trimethoprim); ars (arsenic). Region 2 confers the following resistance: tetA (tetracycline), sul1 
(sulfonamides), aadA1 (aminoglycosides), mer (mercury).
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Emergence of extended- spectrum β-lactam blaCTX- M- 65 clones 
in England and Wales was first observed in human S. enterica 
Infantis isolates between 2010 and 2012 in a previous study 
[60], and in the current study from 2013 (Fig. 4, Table S1). 
blaCTX- M- 65 ESBL- producing S. enterica Infantis has previously 
been described in Europe, and South and North America 
[4, 5, 10, 11, 59]. The number of blaCTX- M- 65 isolates being 
reported in England and Wales between 2013 and 2018 
increased, with 21/42 isolates reported seen in 2018 (Table 
S2).
Of public- health concern is the fact that in England and 
Wales, ESBL- producing S. enterica Infantis isolates between 
2013 and 2018 were isolated from humans as well as retail 
poultry products imported from South America (Tables 
S1 and S2). As with previously reported global S. enterica 
Infantis isolates, phenotypic and genotypic AMR analysis also 
showed resistance to multiple drugs, including trimethoprim/
sulfamethoxazole and ciprofloxacin, two drugs recommended 
for therapy of Salmonella infections when therapy is indicated 
(Table S3) [5, 9, 59]. Additionally, 28 out of the 42 isolates in 
the current study also contained resistance determinants for 
fosfomycin, an agent used to treat urinary tract infections [61] 
(Table S2). Recently, a clonal lineage of azithromycin- resistant 
S. enterica Infantis with ESBL enzymes has been reported 
in Peru [10]. These ESBL- producing isolates also harbour 
genes associated with heavy metal resistance, such as arsenic 
(ars operon) and mercury (mer operon) resistance (Fig. 3), 
as previously shown [62, 63]. Arsenic has been utilized in 
agriculture and poultry for antimicrobial purposes since 
the 1940s in the USA [62], and mercury has been utilized as 
medication for plant diseases and in pesticides [63]. Studies 
have shown co- resistance to metals and multiple antimicro-
bial classes in Gram- negative bacteria [64]. The co- existence 
of metal- resistance and AMR genes on the same genetic locus 
and the horizontal transfer of these co- located determinants 
through the S. enterica Infantis population is capable of 
disease requiring antimicrobial treatment and, hence, poses 
a threat to public health. Taken together, the results from this 
study and others demonstrate a highly resistant serovar that 
is perhaps more difficult to treat.
The emergence of MDR and ESBL- producing S. enterica 
Infantis has been connected with the presence of a unique 
Fig. 4. (a) Maximum- likelihood phylogeny of 795 S. enterica Infantis isolates. Clade 1 represents the 368 isolates with pESI- like plasmids. 
Forty- two isolates harbouring bla
CTX- M- 65
 fell into a sub- clade (purple). Another isolate (hPHE_159) that fell into this cluster did not harbour 
the bla
CTX- M- 65
 gene. Inner ring – isolation source: human (orange), food (red), animal (gold), other (brown) and unknown (grey). Second 
ring – association with foreign travel: Asia (blue), Africa (green), Europe (yellow), North America (brown), South America (red), unknown 
destination (black), unknown (grey) and no travel (white). Third ring – pESI- like plasmid presence. Outer ring – isolates carrying bla
CTX- M- 65
 
on a pESI- like plasmid. (b) Heat map showing the presence/absence of AMR genes in the 43 isolates that fell into the bla
CTX- M- 65
 subclade 
in (a). Only isolate hPHE_159 did not harbour the bla
CTX- M- 65
 gene. 1, aac(3)IV; 2, aac(6)Iaa; 3, aadA; 4, aph(3')- Ia; 5, aph(4)- Ia; 6, bla
CTX- M- 65
; 7, 
dfrA14; 8, floR; 9, fosA3; 10, sul1; 11, tet(A).
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pESI or pESI- like megaplasmid that enhances the fitness of 
the bacterium [4, 5, 9, 59]. The stability of pESI is presumed 
to benefit from the presence of three type II addiction (toxin–
antitoxin) systems that were found in the plasmid, and such 
systems are believed to contribute to plasmid maintenance 
and prevalence during vertical transmission [65].
Genome analysis revealed the presence of a pESI- like 
megaplasmid of approximately 320 kbp in isolate 114061 
(SRR6854755) and the presence of pESI- like plasmids in the 
other 368/795 S. enterica Infantis isolates studied between 
2000 and 2017 (Table S1, Figs S1 and S2). pESI- like plasmids 
from human S. enterica Infantis isolates have been seen in 
the UK as early as 2000 and the first blaCTX- M- 65 isolate seen in 
2013 (Tables S1 and S2).
Using PlasmidFinder, we confirmed the presence of an 
IncFIB- like incompatibility group replicon in the complete 
sequences of an English human S. enterica Infantis isolate 
from 2015 (isolate 114061). Using brig (blast Ring Imaging 
Tool) and blastn, the pESI- like plasmid from 114061 
(SRR6854755) shared 99 % sequence identity with a plasmid 
from a chicken S. enterica Infantis isolate from the USA [5] 
(Fig. 3). The plasmid contained genes conferring enhanced 
colonization capability and biofilm formation (ipf and fae 
fimbriae operons), virulence [fimbriae, yersiniabactin (ybt 
operon)], resistance and fitness [tet, dfrA and sul1 genes 
and genes related to tolerance to heavy metals (mer and ars 
operons) in the intensive- farming environment, as seen in 
the pESI plasmid from Israel [9], with additional resistance 
genes blaCTX- M- 65 and fosA conferring resistance to ESBL and 
fosfomycin (Figs 3, S1 and S2) . The high degree of similarity 
between the pESI and pESI- like plasmids suggests common 
ancestry of these plasmids, and these plasmids are potentially 
acquiring different resistance determinants horizontally, most 
likely due to selection pressures in intensive poultry farm 
settings, as S. enterica Infantis is strongly associated with 
poultry [6, 8, 15].
Variations are often observed in the two drug regions found 
on pESI or pESI- like plasmids [4, 5, 59]. In this study, the 
42 blaCTX- M- 65 isolates from humans and food exhibited six 
different AMR profiles with resistance ranging from eight anti-
microbial classes [including isolate 114061 (SRR6854755)] to 
six antimicrobial classes (Table S2). One isolate (SRR6191309) 
did not have the tet(A)−1 and sul1 genes in region 2 (AMR 
profile 4) that was described in the original pESI plasmid 
(Table S2) [9]. The variability in resistance gene composi-
tions would be expected, since the resistance genes were 
surrounded by transposases and/or integrases, suggesting 
that they would be mobile.
Phylogenetic analysis of 795 S. enterica Infantis eBG31 isolates 
between 2000 and 2017, including 42 ESBL- producing isolates, 
was carried out to gain a broader perspective on the distribu-
tion of pESI/pESI- like plasmids and mobile genetic elements/
antimicrobial properties amongst the English and Welsh S. 
enterica Infantis eBG31 population. A total of 368 isolates 
harbouring pESI- like plasmids formed a separate clade (clade 
1), indicating that pESI was introduced into the English and 
Welsh eBG31 population prior to 2000 and clonal expansion 
of these isolates has occurred. Clade 1 consisted of isolates 
from animals, food and humans. The 42 blaCTX- M- 65 isolates 
fell into a lineage within clade 1, 13 of the human isolates 
with known travel history were associated with travel to South 
America and 6 out of the 7 poultry products were imported 
from South America (Fig. 4). Recent studies have shown the 
wide distribution of blaCTX- M- 65 in commensal bacteria in the 
paediatric populations in Bolivia [66], and has been described 
in S. enterica Infantis in the human population in Peru and 
Ecuador [10, 11]. The discovery of blaCTX- M- 65 in pESI- like 
plasmids from South American S. enterica Infantis once again 
highlights the rapid global transmission of a highly drug- 
resistant pathogen through travel or the possible consump-
tion of contaminated food products. Variations in AMR 
profiles are expected due to the plasticity of both the drug 
regions in the pESI- like plasmid and the varying sampling 
(in this study it’s biased towards clinical isolates that PHE 
receives) and sequencing times of the samples (Fig. 3). Even 
though the isolates were collected over a period of 17 years 
and from different sources, such as humans and poultry food 
products, the small genetic distance between the blaCTX- M- 65 
lineage isolates suggests a strain that likely spread by clonal 
expansion in the recent past and has been in circulation for 
some time (Fig. 4a).
The presence of pESI- like plasmids in the S. enterica Infantis 
population in England and Wales since 2000 and the blaCTX-
 M- 65 ESBL isolates since 2013 has shown the emergence of a 
stable resistant clone that has been in circulation for some 
time in the human population. The limitation of the study 
was that 33/35 of the food isolates were poultry related but 
had no known country of origin (other than the 6 ESBL South 
American isolates) (Table S1). Therefore, this investigation 
does not resolve the source of introduction to either humans 
or animals, but does highlight how easily resistant bacteria 
can spread globally and suggests the possible introduction 
of ESBL S. enterica Infantis into England and Wales from 
travel or imported poultry products from South America. 
These findings also show the importance of using WGS data 
for integrated epidemiological, phylogenomics and AMR/
virulence surveillance to compare animal, human and food 
isolates. As a result, we will be equipped not only to detect 
the transmission of the pathogen but also to identify different 
sources and mechanisms of resistance/virulence that will 
allow us to design more effective interventions and thorough 
risk- management strategies.
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